SEC Filings | Madrigal Pharmaceuticals.

Filing date	Form	Description	View
June 20, 2023	8-K	Report of unscheduled material events or corporate event	0001193125-23-169187.pdf 0001193125-23-169187.rtf 0001193125-23-169187.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
June 20, 2023	8-K	Report of unscheduled material events or corporate event	0001193125-23-169190.pdf 0001193125-23-169190.rtf 0001193125-23-169190.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
June 20, 2023	3	Initial filing by director officer or owner of more than ten percent.	0001209191-23-038211.pdf 0001209191-23-038211.rtf 0001209191-23-038211.xls
June 20, 2023	3	Initial filing by director officer or owner of more than ten percent.	0001209191-23-038212.pdf 0001209191-23-038212.rtf 0001209191-23-038212.xls
June 20, 2023	4	Statement of changes in beneficial ownership of securities	0001209191-23-038346.pdf 0001209191-23-038346.rtf 0001209191-23-038346.xls
June 20, 2023	4	Statement of changes in beneficial ownership of securities	0000899243-23-016060.pdf 0000899243-23-016060.rtf 0000899243-23-016060.xls
June 20, 2023	4	Statement of changes in beneficial ownership of securities	0000899243-23-016057.pdf 0000899243-23-016057.rtf 0000899243-23-016057.xls
June 20, 2023	4	Statement of changes in beneficial ownership of securities	0000899243-23-016056.pdf 0000899243-23-016056.rtf 0000899243-23-016056.xls
June 20, 2023	4	Statement of changes in beneficial ownership of securities	0000899243-23-016059.pdf 0000899243-23-016059.rtf 0000899243-23-016059.xls
May 09, 2023	10-Q	Quarterly report which provides a continuing view of a company's financial position	0001193125-23-138863.pdf 0001193125-23-138863.rtf 0001193125-23-138863.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA

Data provided by Kaleidoscope.